cas 1887015-55-5|| where to buy 5-fluoro-1-methyl-6-oxopyridine-2-carbonitrile

Nom du produit:5-fluoro-1-methyl-6-oxopyridine-2-carbonitrile

IUPAC Name:5-fluoro-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile

Unité d'emballage	Stock disponible	Prix($)
CM325449-100mg	in stock	țưŴ
CM325449-250mg	in stock	ƀƦț
CM325449-1g	1-2 Weeks	ƦȬŴŴ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1887015-55-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1887015-55-5; Formule moléculaire:C7H5FN2O; Point de fusion:-; Code SMILES:N#CC1=CC=C(F)C(N1C)=O; Densité:

: Numéro de catalogue:CM325449; Poids moléculaire:152.13; Point d'ébullition:; N° Mdl:; Stockage:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Olutasidenib; Rigel announces publication of data on REZLIDHIA(Olutasidenib) in post-venetoclax patients with mutant IDH1 AML in Leukemia & Lymphoma.
REZLIDHIA (Olutasidenib), a potent, selective, oral, small-molecule inhibitor of mutant isocitrate dehydrogenase-1 (mIDH1), in patients with mIDH1 acute myeloid leukemia (AML) who were relapsed/refractory (R/R) to prior venetoclax-based regimens.